~~<i id='D748F1EFCD'><strike id='D748F1EFCD'><tt id='D748F1EFCD'><pre id='D748F1EFCD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：fashion 2025-10-02 22:58:51 - browse：2786

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： 3 questions for the future of Biden's cancer moonshot

explore

Wikipedia

focus

hotspot

explore

InhisStateoftheUnionaddress,PresidentBidenwillproposeexpandingseveralofDemocrats'drugpricingreformsi

WSS

Streamlined flu vaccines recommended by FDA advisory panel

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Longer MASH drug regimen improved liver, Akero study finds

Pregnant women don't need prenatal multivitamins, study concludes

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Harvard's David Sinclair gets blowback over aging

leisure time

fashion

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA rejects Alnylam's heart disease treatment over insufficient data

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA panel signals lack of confidence in Amgen cancer drug data

Malaria cases in Florida and Texas: Here’s what you need to know

Sana to lay off nearly a third of staff, de

Sports medicine is finally prioritizing gender equality

The future of health care in the House

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Wikipedia

Readout Newsletter: BridgeBio, Akero, and human embryo models

He's 19 months old and has one of the world’s rarest diseases

Ozempic has benefits for kidney disease as well as diabetes

Ozempic has benefits for kidney disease as well as diabetes

Why age limits for politicians are a terrible idea

Stem cell biologist probes earliest stages of human development

focus

hotspot

hotspot

explore